SCHEMBL855324

SCHEMBL855324

CCCCN1CCCC(CN)C1

nearest known ligand 0.51

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
BCHE P06276 7/20 0.49
BACE1 P56817 1/20 0.42
GNAI3 P08754 1/20 0.40
GNAO1 P09471 1/20 0.40
GNAI1 P63096 1/20 0.40
NCF1 P14598 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL856491 0.89 NCF1 (0.47) BCHEGNAI3GNAO1GNAI1NCF1
SCHEMBL2425235 0.89 DRD2 (0.47) NCF1
SCHEMBL27281617 0.85 BCHE (0.47) BCHE
Fluoride SCHEMBL30330735 0.84 BCHE (0.46) BCHE
SCHEMBL16341416 0.84 BCHE (0.46) BCHEBACE1
SCHEMBL5119116 0.84 GNAO1 (0.53) BCHEGNAI3GNAO1GNAI1NCF1
SCHEMBL2433914 0.82 BCHE (0.49) BCHE
Hydrochloric Acid SCHEMBL30212680 0.82 BCHE (0.45) BCHEBACE1GNAO1
Fluoride SCHEMBL29253011 0.82 CYP1A2 (0.48) BCHEBACE1
SCHEMBL2433913 0.82 BCHE (0.49) BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2640366-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE Exelixis, Inc. (US) 2013-09-25 EP disclosed
WO-2012068096-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE EXELIXIS, INC. (US) 2012-05-24 WO disclosed
EP-2432779-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES Exelixis, Inc. (US) 2012-03-28 EP disclosed
WO-2010135524-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES EXELIXIS, INC. (US) 2010-11-25 WO disclosed